Medicines and Society
Medicines have enormous impact on the people and societies that use them.
When new medicinal compounds are approved for the Danish market, their efficacy and safety must be documented in clinical trials. This is done to ensure, that patients and society get the most effective, safest and cheapest drugs.
Additionally, knowledge of the correct use of drugs is essential to avoid overuse, misuse or other irrational use. Information and communication are vital factors here.
Professional profiles
The Medicines and Society track provides the opportunity for various professional profiles, such as:
Within clinical development, you focus on investigating the effect of drugs on healthy research subjects and on groups of patients under controlled conditions.
The controlled clinical trial is the gold standard for this process and provides the basic documentation for the efficacy and adverse effect profile of a drug.
Within regulatory affairs, you focus on registration strategies as well as on guiding and coordinating drug development.
The regulatory authorities have stringent requirements for the efficacy and quality of medicines. Before a new medicinal product is approved, companies must document that their product meets these many requirements.
People working with regulatory affairs are responsible for submitting documentation and for the communication between the authorities and companies.
Within social pharmacy, you focus on the position of medicines in society; this includes the use of drugs, the financial elements and healthcare policies.
The perspectives of both patients and of the healthcare services on the use of drugs are central. Key topics are marketing, economics, distribution, communication, compliance (the extent to which patients follow the instructions given), monitoring (control and supervision), and the individualisation of drug use.